Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.75 Analyst target: $25.00 Upside: 426.32%
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.
See the full interactive analysis & chart →Informational only — not investment advice.